Spring til hovednavigation Spring til søgning Spring til hovedindhold

Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1

  • Michael D Crowther
  • , Garry Dolton
  • , Mateusz Legut
  • , Marine E Caillaud
  • , Angharad Lloyd
  • , Meriem Attaf
  • , Sarah A E Galloway
  • , Cristina Rius
  • , Colin P Farrell
  • , Barbara Szomolay
  • , Ann Ager
  • , Alan L Parker
  • , Anna Fuller
  • , Marco Donia
  • , James McCluskey
  • , Jamie Rossjohn
  • , Inge Marie Svane
  • , John D Phillips
  • , Andrew K Sewell
220 Citationer (Scopus)

Abstract

Human leukocyte antigen (HLA)-independent, T cell-mediated targeting of cancer cells would allow immune destruction of malignancies in all individuals. Here, we use genome-wide CRISPR-Cas9 screening to establish that a T cell receptor (TCR) recognized and killed most human cancer types via the monomorphic MHC class I-related protein, MR1, while remaining inert to noncancerous cells. Unlike mucosal-associated invariant T cells, recognition of target cells by the TCR was independent of bacterial loading. Furthermore, concentration-dependent addition of vitamin B-related metabolite ligands of MR1 reduced TCR recognition of cancer cells, suggesting that recognition occurred via sensing of the cancer metabolome. An MR1-restricted T cell clone mediated in vivo regression of leukemia and conferred enhanced survival of NSG mice. TCR transfer to T cells of patients enabled killing of autologous and nonautologous melanoma. These findings offer opportunities for HLA-independent, pan-cancer, pan-population immunotherapies.

OriginalsprogEngelsk
TidsskriftNature Immunology
Vol/bind21
Udgave nummer2
Sider (fra-til)178-185
Antal sider8
ISSN1529-2908
DOI
StatusUdgivet - feb. 2020

Fingeraftryk

Dyk ned i forskningsemnerne om 'Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1'. Sammen danner de et unikt fingeraftryk.

Citationsformater